Real‐world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

医学 心脏再同步化治疗 射血分数 内科学 心力衰竭 心脏病学 左束支阻滞 临床终点 植入式心律转复除颤器 心房颤动 加拿大心血管学会 生活质量(医疗保健) 临床试验 心肌梗塞 护理部 心绞痛
作者
Ignacio Garcı́a-Bolao,Roy S. Gardner,Daniel Gras,Antonio D’Onofrio,George E. Mark,Devi G. Nair,Nicolas Lellouche,Miroslav Novák,Ronald Lo,E. W. Chew,David J. Wright,Andrew J. Kaplan,Matteo Bertini,Sara Veraghtert,Michelle M. Harbin,Elizabeth Matznick,Patrick Yong,Kenneth M. Steín
出处
期刊:Esc Heart Failure [Wiley]
标识
DOI:10.1002/ehf2.15190
摘要

Abstract Aims Cardiac resynchronization therapy (CRT) is guideline recommended for the treatment of symptomatic heart failure (HF) with reduced left ventricular ejection fraction and prolonged QRS. However, patients with common comorbidities, such as persistent/permanent atrial fibrillation (AF), are often under‐represented in clinical trials. Methods The Strategic Management to Optimize Response to Cardiac Resynchronization Therapy (SMART) registry (NCT03075215) was a global, multicentre, registry that enrolled de novo CRT implants, or upgrade from pacemaker or implantable cardioverter defibrillator to CRT‐defibrillator (CRT‐D), using a quadripolar left ventricular lead in real‐world clinical practice. The primary endpoint was CRT response between baseline and 12 month follow‐up defined as a clinical composite score (CCS) consisting of all‐cause mortality, HF‐associated hospitalization, New York Heart Association (NYHA) class and quality of life global assessment. Results The registry enrolled 2035 patients, of which 1558 had completed CCS outcomes at 12 months. The patient cohort was 33.0% female, mean age at enrolment was 67.5 ± 10.4 years and the mean left ventricular ejection fraction was 29.6 ± 7.9%. Notably, there was a high prevalence of mildly symptomatic patients (NYHA class I/II 51.3%), non‐left bundle branch block (LBBB) morphology (38.0%), AF (37.2%) and diabetes mellitus (34.7%) at baseline. CCS at 12 months improved in 58.9% ( n = 917) of patients; 20.1% ( n = 313) of patients stabilized and 21.0% ( n = 328) worsened. Several patient characteristics were associated with a lower likelihood of response to CRT including older age, ischaemic aetiology, renal dysfunction, AF, non‐LBBB morphology and diabetes. Higher HF hospitalization ( P < 0.001) and all‐cause mortality ( P < 0.001) were observed in patients with AF. These patients also had lower percentages of ventricular pacing than patients in sinus rhythm at baseline and follow‐up ( P < 0.001, both). A further association between AF and non‐LBBB was observed with 81.4% of AF non‐LBBB patients experiencing an HF hospitalization compared with 92.5% of non‐AF LBBB patients (P < 0.001). Mortality between subgroups was also statistically significant ( P = 0.019). Conclusions This large, global registry enrolled a CRT‐D population with higher incidence of comorbidities that have been historically underrepresented in clinical trials and provides new insight into factors influencing response to CRT. As defined by CCS, 58.9% of patients improved and 20.1% stabilized. Patients with AF had particularly worse clinical outcomes, higher HF hospitalization and mortality rates and lower percentages of ventricular pacing. High incidence of HF hospitalization in patients with AF and non‐LBBB in this real‐world cohort suggests that ablation may play an important role in increasing future CRT response rates.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
复杂芷文完成签到,获得积分10
3秒前
MM完成签到 ,获得积分10
3秒前
ty完成签到 ,获得积分10
5秒前
猪猪hero完成签到,获得积分10
6秒前
潮哥完成签到 ,获得积分10
7秒前
岁见发布了新的文献求助10
10秒前
秀丽颤完成签到,获得积分10
12秒前
12秒前
13秒前
Harlotte完成签到 ,获得积分0
15秒前
慕青的应助被霖29采纳,获得10
15秒前
黑米粥发布了新的文献求助200
16秒前
18秒前
cloud完成签到 ,获得积分10
20秒前
李健的应助被岁见采纳,获得10
21秒前
酷酷的幼菱完成签到 ,获得积分10
22秒前
26秒前
黑米粥发布了新的文献求助200
26秒前
月昔完成签到 ,获得积分10
27秒前
isedu完成签到,获得积分0
28秒前
大方碧完成签到,获得积分10
29秒前
bkagyin的应助被科研通管家采纳,获得10
32秒前
霖29发布了新的文献求助10
33秒前
orange完成签到,获得积分10
42秒前
43秒前
44秒前
科研通AI6.2的应助被小小旭呀采纳,获得10
45秒前
48秒前
潇洒夏天完成签到,获得积分10
50秒前
黑米粥发布了新的文献求助200
51秒前
51秒前
岁见发布了新的文献求助10
52秒前
阿俊1212完成签到 ,获得积分10
55秒前
洁净友蕊完成签到,获得积分10
56秒前
小小旭呀发布了新的文献求助10
57秒前
无辜秋尽完成签到,获得积分10
58秒前
可耐的万言完成签到 ,获得积分10
1分钟前
英俊的铭的应助被yhr采纳,获得20
1分钟前
随风沙ZYX完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185501
求助须知:如何正确求助?哪些是违规求助? 9574179
关于积分的说明 21834528
捐赠科研通 7783108
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558949
邀请新用户注册赠送积分活动 2481357